8
Total deals
$2.2B
Total value
$369.9M
Avg deal
$615.4M
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
ChemGenex Pharmaceuticals
ChemGenex Pharmaceuticals Ltd, an integrated biopharmaceutical development compa…
|
2011-03-29 | Acquisition | Complete | $225.0M | Deal → |
| 2 |
Gemin X Pharmaceuticals
Gemin X Pharmaceuticals develops and commercializes targeted cancer therapeutics…
|
2011-03-21 | Merge | Complete | $525.0M | Deal → |
| 3 |
Ception Therapeutics
Ception Therapeutics is a biopharmaceutical company developing novel products to…
|
2010-02-23 | Acquisition | Complete | $250.0M | Deal → |
| 4 |
Mepha Pharma
Mepha Pharma is a innovative pharmaceutical developing, manufacturing and market…
|
2010-02-01 | Acquisition | Complete | $615.4M | Deal → |
| 5 |
BioAssets Development
BioAssets Development Corporation, a biopharmaceutical company, develops spine i…
|
2009-10-26 | Acquisition | Complete | — | Deal → |
| 6 |
A
Arana Therapeutics
Arana Therapeutics is a biopharmaceutical company that develops next generation …
|
2009-08-11 | Acquisition | Complete | — | Deal → |
| 7 |
Salmedix
It focuses on the treatment of hematologic malignancies or blood cancers.
|
2005-05-12 | Acquisition | Complete | $160.0M | Deal → |
| 8 |
A
Anesta
Anesta is the creator of pharmaceutical products designed for oral transmucosal …
|
2000-07-18 | Acquisition | Complete | $444.0M | Deal → |